Voya Financial Advisors’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-6,012
| Closed | -$269K | – | 660 |
|
|
2020
Q4 | $269K | Buy |
+6,012
| New | +$269K | 0.01% | 544 |
|
|
2020
Q3 | – | Sell |
-6,671
| Closed | -$232K | – | 586 |
|
|
2020
Q2 | $232K | Sell |
6,671
-922
| -12% | -$32.1K | 0.01% | 526 |
|
|
2020
Q1 | $217K | Sell |
7,593
-414
| -5% | -$11.8K | 0.01% | 514 |
|
|
2019
Q4 | $419K | Sell |
8,007
-731
| -8% | -$38.3K | 0.02% | 433 |
|
|
2019
Q3 | $471K | Sell |
8,738
-314
| -3% | -$16.9K | 0.03% | 397 |
|
|
2019
Q2 | $357K | Sell |
9,052
-222
| -2% | -$8.76K | 0.02% | 451 |
|
|
2019
Q1 | $277K | Buy |
9,274
+96
| +1% | +$2.87K | 0.02% | 498 |
|
|
2018
Q4 | $293K | Buy |
9,178
+843
| +10% | +$26.9K | 0.02% | 436 |
|
|
2018
Q3 | $352K | Buy |
8,335
+1,499
| +22% | +$63.3K | 0.02% | 446 |
|
|
2018
Q2 | $214K | Buy |
6,836
+1,802
| +36% | +$56.4K | 0.01% | 520 |
|
|
2018
Q1 | $249K | Buy |
5,034
+1,057
| +27% | +$52.3K | 0.02% | 478 |
|
|
2017
Q4 | $212K | Buy |
3,977
+218
| +6% | +$11.6K | 0.01% | 521 |
|
|
2017
Q3 | $219K | Buy |
+3,759
| New | +$219K | 0.01% | 475 |
|